Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Cipla Ltd.
Swot
Cipla Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Cipla Ltd. has 19 Strengths, 6 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(19)
Weakness
(6)
Opportunity
(3)
Threats
(2)
Others
(3)
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Consistent Highest Return Stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
MACD Crossover Below Signal Line
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
MACD crossed below signal line previous end of day
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Highest FII stock holdings
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
US FDA Warning Letter
Red Flag: Companies seeing significant coronavirus impact
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)